Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results

Overview of attention for article published in European Urology, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 5 news outlets
twitter: 58 X users
facebook: 1 Facebook page

googleplus: 1 Google+ user
guideline: 2 clinical guideline sources

Readers on

mendeley: 168 Mendeley

So far, Altmetric has seen 5 public wall posts from 1 users.

European Urology, 26 Oct 2017

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma Aft Nephrectomy: Subgroup Analyses

European Urology, 22 Oct 2017

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma Aft Nephrectomy: Subgroup Analyses

European Urology, 16 Oct 2017

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma Aft Nephrectomy: Subgroup Analyses

European Urology, 12 Oct 2017

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma Aft Nephrectomy: Subgroup Analyses

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 1 additional Facebook posts.